Celularity (CELU)

• Market cap: $52.8M
• 1 day: -7.04%
• 5 days: -5.71%
• 1 month: -7.91%
• 3 months: -10%
• 6 months: 26.92%
• Year to date: -10%
• 1 year: -23.85%
• 5 years: -98.12%
• 10 years: -97.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Employees: 123